Impaired Immunogenicity of Hepatitis B Vaccine in Obese Persons

Authors
Publication date
1 January 1986
Publisher
Doi

    Abstract

    To the Editor: The plasma-derived hepatitis B vaccine (Heptavax B, Merck Sharp & Dohme) is currently recommended for medical personnel at high risk of acquiring hepatitis B

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Carolina Digital Repository

      redirect
      oaicdr.lib.unc.edu:6h441017j
      Last time updated on 24/11/2020